Completed PHASE1 INTERVENTIONAL 1-arm NCT02172885

Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta (TERCELOI)

Sponsor: Hospital Infantil Universitario Niño Jesús, Madrid, Spain

Updated 7 times since 2017 Last updated: Sep 29, 2023 Started: Apr 30, 2014 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Osteogenesis Imperfecta and is currently completed. Hospital Infantil Universitario Niño Jesús, Madrid, Spain leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Nov 2023 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Nov 2023 [monthly]

Completed PHASE1
Apr 2019 — Jan 2021 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed

▶ Show 2 earlier versions

Jun 2018 — Apr 2019 [monthly]

Active Not Recruiting PHASE1
Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE1

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Infantil Universitario Niño Jesús, Madrid, Spain
Hospital Universitario Getafe
Hospital de Cruces

Data source: Hospital de Cruces

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barakaldo, Spain
• Getafe, Spain